Diagnostics Pipeline: Labcorp Launches Holistic Medicine Service
The company is offering whole panels and more than 1,000 assays in total to support the new products
Keep up to date on new and emerging diagnostic tests, testing trends and opportunities, and disruptive technologies
The company is offering whole panels and more than 1,000 assays in total to support the new products
A new assay uses AI-optimized enzymes to simplify and increase the accuracy of rapid pathogen detection.
Accessible screening tests and inclusive management strategies may limit the global cervical cancer incidence rate.
New program aims to provide greater transparency on the recommended performance characteristics of such tests.
Multiorgan analysis of biobank data elucidates heart–brain links that could enhance disease prevention and detection.
The agency recently announced it will decide in December whether to grant clearance for a CRISPR therapy for treating sickle cell disease.
Automation software uses advanced computational tools to generate gapless genome sequences in just a couple of days.
Although PRS technology and adoption still have a way to go, it is progressing quickly, especially in the cancer and oncology space.
Free open-source software can be leveraged across diagnostic processes—how can your organization benefit from it?
Christian Olsen, a leader in R&D scientific software, discusses recent developments related to AI and solutions to current precision medicine challenges.
In early May, GSK’s Arexvy became the first RSV vaccine to be cleared by the FDA for use in the US in adults aged 60 and up.